Koninklijke Philips N.V.'s shares declined by nearly 8% on Friday after the United States Food and Drug Administration (FDA) ordered the withdrawal of millions of the company's ventilators aimed at treating sleep apnea.
The FDA said the information Philips shared cast doubt users can use the devices without any risks.
The company's shares on Euronext Amsterdam plunged by 7.80% at 1:49 pm CET to sell for approximately €17.28 per share. Meanwhile, its stock in the United States plummeted by 8.42% in the premarket, going for $18.05 per share at 7:51 am ET.
